Nature Communications (Feb 2023)
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation
Abstract
Antigen-specific tolerance represents a promising strategy to treat type 1 diabetes and islet allograft rejection. Here, the authors deliver immune signals to lymph nodes to promote antigen-specific regulatory T cells and prevent disease in models of type 1 diabetes and allogenic islet transplantation.